중국의 바이오 기반 재료 시장 : 뉴스레터(분기별)

In Sept., China's MIIT and the other departments jointly issued an implementation plan for the high-quality development of the raw

materials industry, with the development of bio-based materials listed as one of the primary tasks.

Jindan Technology reported operating revenue and net profit for H1 with huge year-on-year increases and moving forward with a new

PLA project, the designed capacity of which has been scaled up from 10,000 t/a to 75,000 t/a; while Kingfa's net profit tumbled, deferring its plan for putting the 30,000 t/a PLA project into operation.

Zhongke Biotech and Cathay Biotech both delivered remarkable financial performance for H1 2022. The two companies have

been actively setting up production capacities of long-chain dibasic acids (LCDAs) and bio-based polyamides (PAs).

On 16 Aug., Hisun Biomaterials made IPO on the Shanghai's STAR Market, boasting fast-growing revenue and sustainable capacity

improvement of PLA over the past three years.

COFCO Biotech reported a 12.21% year-on-year increase in its net profit for H1 2022, with ongoing initiatives to propel biodegradable

materials PHA, PLA, and lactide projects.

In this Q3, China sees new developments in PLA industry, including projects in Jiangxi Keyuan and Langjing New Material, and the

proposal for 300,000 t/a PLA construction raised by Zhongke Baichuang Environmental Biotechnology (Guantao) Co., Ltd.

In Aug.-Sept., two new bio-based fibre projects were publicised and one bio-based fibre composite project was resubmitted for approval to proceed.

On 6 Sept., BBCA Biochemical published an EIA report (exposure draft) of its 5,000 t/a D-lactic acid industrialisation demonstration

project and the 3,000 t/a PLA industrialisation demonstration project.

On 31 Aug., the EI report of Zhangjiagang Jiutai's 30,000 t/a PTT new bio-based material project was approved.

In Aug., the EI reports for the bio-based new material (bamboo-based cellulose) constructions of Jinzhu New Material and Anhui Huizhu

were posted for public review, the 1st phase of each accounts for capacity of 100,000 t/a.

Bio-based Material Quarterly Newsletter provides you with real-time intelligence on China's biomaterial market.

This newsletter will help you stay ahead of the game in this fast-changing market with real-time reporting on the entire bio-based materials industry chain, from raw materials to end consumption. It includes breaking news from China and abroad, the latest market data (price, import & export, production, consumption, operating rates, etc.), in-depth analysis of market trends, and expert commentary from industry insiders.

Table of Contents

Headline

Editor's Note

Governmental Direction

China releases implementation plan for high-quality raw material industry development

Market Analysis

Jindan Technology and Kingfa release performance reports for H1

Zhongke Biotech & Cathay Biotech: Developments in LCDA and PA projects

Hisun Biomaterials makes debut on Shanghai's STAR Market

COFCO Biotech progresses biodegradable materials projects

Company Dynamics

Advance of China's PLA projects

New bio-based fibre / fibre composite projects in China

BBCA Biochemical drafts 5,000 t/a D-lactic acid and 3,000 t/a PLA industrialisation projects

Zhangjiagang Jiutai to produce PTT new bio-based material

Publicity of bio-based projects of Jinzhu New Material and Anhui Huizhu

Price Update

News in Brief

Angel Yeast and Weigou Workshop to co-found China's biggest 30,000 t/a PHA production base

Huakang Pharma planning 2 million t/a corn processing project including LA and PLA

CellUranics closes tens of millions RMB of angel financing

GS Biotech's bio-based degradable materials base project kicks start construction

Huaheng Biotech pushes SA and PDO industrialisation

Puyang Baiaomaisi initiates operation of 50 t/a FDCA pilot-scale equipment

Zhongshan Co-polymer approved for starch-based biodegradable material project